Posts

Study finds spiritual coping behaviors may be key to en...

PHILADELPHIA (September 14, 2023) – High rates of firearm injury among urban Bla...

‘Lab-on-a-drone’ sends science skyward to keep track of...

Polluted air can contribute to the development of asthma and other conditions, a...

UCI researchers announce publication of an open-label c...

Irvine, CA – Sept. 14, 2023 – UCI researchers have found that a simple sugar, N-...

Angkana Rüland to receive illustrious New Horizons Prize

The mathematician Prof. Dr. Angkana Rüland from the Hausdorff Center for Mathema...

Grant funds study of video game for preventing unintend...

Weill Cornell Medicine has been awarded a five-year, $5 million grant from the U...

Clinical whole genome sequencing test developed at JAX

Until quite recently, it was extremely difficult to detect the variants underlyi...

Lego-like gene editing tool lets researchers improve ca...

SAN FRANCISCO, CA—In recent years, scientists have used gene modification techno...

AI-driven tool makes it easy to personalize 3D-printabl...

As 3D printers have become cheaper and more widely accessible, a rapidly growing...

Nourishing Your Aging Brain: The Power Of Medicinal Mus...

As we journey through life, the aging process brings with it a host of changes, ...

Ahead of the seasonal spike, Pfizer and BioNTech’s Covi...

The U.S. FDA has taken a significant step by approving modified mRNA vaccines fo...

Novo Nordisk’s Wegovy Launch in UK Amid Competition

Novo Nordisk has initiated the rollout of its Wegovy weight loss injection in th...

Arbutus Halts COVID-19 RNA Destabilization Projects Aft...

Arbutus Biopharma has undertaken a substantial shift in its strategic direction,...

Menarini signs agreement for Astellas’s rheumatoid arth...

Menarini Asia-Pacific has entered a long-term exclusive agreement to license Ast...

Dewpoint and Chemify partner for cancer drug discovery

Dewpoint Therapeutics entered a collaboration with Chemify to expedite the disco...

Avalo drops three rare disease assets amid ongoing chal...

The company will divest the AVTX-800 rare disease compound series to AUG Therape...

Results from Rybrevant trial solidify Janssen’s foothol...

Currently, NSCLC patients with EGFR exon 19 deletions or L858R substitution face...